pembrolizumab
merck
['keynote-716', 'melanoma', 'pembro']
adjuvant pembro in stage iib/c melanoma from keynote-716 by with statistically significant dmfs difference at 2 years - 88.1 v 82.2 rfs widened a smidge at 2 yrs conclusion? stage ii adjuvant conversation still a tough one #asco22 
Melanoma and high risk skin cancer medical oncologist. Studying hereditary and somatic genomics. CA explant in OH. (IO!) Sports fan, geek, and mommy. Tweets=me.